Skip Ribbon Commands
Skip to main content
Since 1974, the use of EBMT data and statistical resources have resulted in more than 600 publications in peer-reviewed scientific journals. 
Please click on this document to download the Authorship guidelines for EBMT publications

Use the various filters on the table to sort the publications by year, WP, publication title, 1st listed author, journal, PMID.

2017ALWPA comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.Piemontese SJ Hematol Oncol. 28103944
2017ALWPAllogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.Pavlů JCancer28211939
2017CMWPAllogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert Witte TBlood28096091
2017ALWPAllogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Poiré XJ Hematol Oncol. 28100265
2017EBMTAlloreactivity: the Janus-face of hematopoietic stem cell transplantation.Gratwohl ALeukemia. 28270691
2017PDWPFertility preservation practices in pediatric and adolescent cancer patients undergoing HSCT in Europe: a population-based survey.Diesch TBone Marrow Transplant. 28112743
2017CMWPHigh dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: A retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation.Cook GHaematologica.27634201
2017ALWPImpact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT.Canaani JAm J Hematol.28052366
2017ALWPImpact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia WorkingRubio MTJ Hematol Oncol. 28118857
2017ALWPImproving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Giebel SHaematologica27686376
2017EBMTOutcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis.Ustun CLeukemia28119528
2017EBMTPneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.Cordonnier CJ Antimicrob Chemother. 28122911
2017CMWPRisk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation.Schetelig JBone Marrow Transplant. 28112746
2017ALWPRisk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.Battipaglia GBone Marrow Transplant. 28092357
2017IEWPUse of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation.Yeates LBone Marrow Transplant.28092354
2017EBMTUse of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.Passweg JRBone Marrow Transplant.28287639
2017ALWPValidation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.Shouval RAm J Hematol.28181279
2016IEWPA prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis.Speckmann CJ Allergy Clin Immunol.27658761
2016CMWPAllogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.Robin MBone Marrow Transplant.27819688
2016CMWPAllogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party.Sobh MLeukemia27118410
2016CMWPAllogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT.Heidenreich SBiol Blood Marrow Transplant.27720995
2016CMWPAntilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.Kröger NN Engl J Med.26735993
2016PDWPAssociation of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation.Huezo-Diaz Curtis PPharmacogenomics J.27779248
2016ALWPAssociation of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.Giebel SOncologist. 26869584
2016ALWPAutologous transplant remains the preferred therapy for relapsed APL in CR2.Ganzel CBone Marrow Transplant. 27088379
2016CMWPComparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the EuropPotter VTBiol Blood Marrow Transplant.27264633
2016CQLWPDevelopment, preliminary usability and accuracy testing of the EBMT 'eGVHD App' to support GvHD assessment according to NIH criteria-a proof of concept.Schoemans HBone Marrow Transplant. 27042834
2016ADWPDoes ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?Oliveira MCBone Marrow Transplant.26642332
2016EBMTECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.Maertens JJ Antimicrob Chemother.27550992
2016EBMTECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.Alanio AJ Antimicrob Chemother.27550991
1 - 30Next